MedTrace Logo

Stereotactic Management of Arrhythmia - Radiosurgery Treatment and Evaluation of Response in Ventricular Tachycardia

NCT05913375 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-10-19

No results posted yet for this study

Summary

Prospective single-arm study investigating the efficacy and safety of non-invasive cardiac radiosurgery for the treatment of ventricular tachycardia (VT) with reduced dose of radiation (20 Gy). The efficacy and safety outcome measures will be compared with historical control - patients treated within the SMART-VT study (NCT04642963) with a single dose of 25 Gy to test the hypothesis that reduced dose of radiation is similarly effective in terms of reduction of VT burden.

Conditions

  • Ventricular Tachycardia

Interventions

RADIATION

Stereotactic Body Radiotherapy

Non-invasive delivery of ablative radiotherapy dose to the arrhythmia substrate defined with electroanatomical mapping (EAM)

Sponsors & Collaborators

  • Leszek Giec Upper Silesian Medical Center of the Medical University of Silesia in Katowice, Poland

    collaborator UNKNOWN

  • Maria Sklodowska-Curie National Research Institute of Oncology

    lead OTHER

Principal Investigators

  • Sławomir Blamek, MD, PhD, MBA · Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch

  • Wojciech Wojakwoski, MD, PhD · Professor Leszek Giec Upper Silesian Medical Center of the Medical University of Silesia in Katowice

  • Marcin Miszczyk, MD, PhD · Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-24
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05913375 on ClinicalTrials.gov